Citigroup
DERM icon

Citigroup’s Journey Medical DERM Stock Holding History

Citigroup’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.8K Buy
4,071
+2,987
+276% +$17.1K ﹤0.01% 5094
2026
Q1 		$5.08K Buy
1,084
+758
+233% +$5.88K ﹤0.01% 5261
2025
Q4 		$2.51K Sell
326
-193
-37% -$1.51K ﹤0.01% 5418
2025
Q3 		$3.69K Sell
519
-3,791
-88% -$27.5K ﹤0.01% 5319
2025
Q2 		$30.9K Buy
+4,310
New +$29.8K ﹤0.01% 4970

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Citigroup's DERM Position: Q2 2026 in Review

Citigroup increased its Journey Medical (DERM) stake by 276% in Q2 2026, buying an estimated $17.1K and bringing the position to 4,071 shares worth $28.8K. The position accounts for ﹤0.01% of the portfolio, ranked #5094.

Citigroup first reported a position in DERM in Q2 2025 and has held it in 5 quarters since. The position peaked at $30.9K in Q2 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Citigroup held 4,071 shares of Journey Medical worth $28.8K as of Q2 2026.
  • Citigroup bought 2,987 Journey Medical shares in Q2 2026, an estimated $17.1K.
  • Journey Medical made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5094 holding.
  • Citigroup first reported a position in Journey Medical in Q2 2025 and has held it in 5 quarters since.
  • Citigroup's Journey Medical position peaked at $30.9K in Q2 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.